Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Director departure Inv. presentation Auditor change
|
Cellular Biomedicine Group, Inc. (CBMG)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/19/2021 |
SC 13D/A
| Liu Tony reports a 0% stake in Cellular Biomedicine Group, Inc. |
08/12/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
08/12/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
06/24/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
06/24/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
06/24/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
04/01/2020 |
SC 13D/A
| Sailing Capital Overseas Investments Fund, LP reports a 8.9% stake in Cellular Biomedicine Group, Inc. |
04/01/2020 |
SC 13D/A
| TF Venture Capital Management Co., Ltd. reports a 1.8% stake in Cellular Biomedicine Group, Inc. |
04/01/2020 |
SC 13D/A
| Liu Tony reports a 5.4% stake in Cellular Biomedicine Group, Inc. |
03/31/2020 |
SC 13D/A
| Dangdal International Group Co. Ltd reports a 11.8% stake in Cellular Biomedicine Group, Inc. |
03/30/2020 |
SC 13D/A
| Hillhouse Capital Advisors, Ltd. reports a 1.2% stake in Cellular Biomedicine Group, Inc. |
02/24/2020 |
SC 13D/A
| Dangdal International Group Co. Ltd reports a 11.8% stake in Cellular Biomedicine Group, Inc. |
02/21/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
02/21/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
02/21/2020 |
SC 13D/A
| Sailing Capital Overseas Investments Fund, LP reports a 8.9% stake in Cellular Biomedicine Group, Inc. |
02/21/2020 |
SC 13D/A
| Liu Tony reports a 5.7% stake in Cellular Biomedicine Group, Inc. |
01/31/2020 |
SC 13D/A
| Dangdal International Group Co. Ltd reports a 11.8% stake in Cellular Biomedicine Group, Inc. |
01/30/2020 |
SC 13D/A
| Liu Tony reports a 5.3% stake in Cellular Biomedicine Group, Inc. |
01/30/2020 |
SC 13D/A
| Hillhouse Capital Advisors, Ltd. reports a 1.2% stake in Cellular Biomedicine Group, Inc. |
11/18/2019 |
SC 13D/A
| Dangdal International Group Co. Ltd reports a 11.8% stake in Cellular Biomedicine Group, Inc. |
12/10/2018 |
SC 13D/A
| Dangdal International Group Co. Ltd reports a 12.3% stake in Cellular Biomedicine Group, Inc. |
11/25/2015 |
SC 13D/A
| Global Health Investment Holdings Ltd. reports a 0% stake in Cellular Biomedicine Group, Inc. |
08/09/2013 |
SC 13D/A
| Wong Keith reports a 8.4% stake in CELLULAR BIOMEDICINE GROUP, INC. |
05/07/2013 |
SC 13D/A
| Wong Keith reports a 8.9% stake in CELLULAR BIOMEDICINE GROUP, INC. |
|
|